How Long Does Orforglipron Stay in Your System?

Orforglipron stays in your system for roughly 6 to 10 days after your last dose, based on its FDA-label elimination half-life of approximately 29 to 49 hours (about 1 to 2 days) and the standard pharmacology estimate of five half-lives to substantially clear a drug. Here’s what the label actually says about how orforglipron is processed, cleared, and built up in your body, and why that timeline matters beyond just curiosity.

What “stays in your system” actually means

“How long does a drug stay in your system” usually gets answered with one number — the half-life, or the time it takes for the concentration in your blood to drop by half. But a single half-life doesn’t mean a drug is gone; it takes several half-lives for a dose to be mostly eliminated. For orforglipron, understanding this matters for two different questions that often get conflated: how long it takes to build up to a stable level in your body (steady state) after starting or increasing a dose, and how long it takes to clear out after your last dose. Those are opposite processes, and the label speaks to both.

If you’re instead asking when orforglipron starts producing appetite or weight effects, that’s a different timeline driven by the titration schedule — see How Long Does Orforglipron Take to Work? for that side of things.

What is orforglipron’s half-life, per the FDA label?

Per the FDA-approved label on DailyMed, orforglipron’s elimination half-life is approximately 29 to 49 hours. That range reflects real variability: half-life measured after a single early dose tends to run shorter than half-life measured once someone is at steady state on a maintenance dose, which is typical for once-daily oral drugs that accumulate somewhat with repeated dosing.

A commonly used pharmacology rule of thumb is that a drug is considered largely cleared from the body after about five half-lives (roughly 97% eliminated). Applying that to orforglipron’s reported range gives a rough window of about 6 to 10 days after the last dose — not a number the label states outright, but a standard estimate based on the half-life it does report. Individual clearance can vary with liver function, other medications, and where you are in the dosing schedule.

How is orforglipron metabolized and eliminated?

Per the FDA label, orforglipron is broken down mainly in the liver by the CYP3A4 enzyme into several metabolites. From there, elimination is overwhelmingly through the digestive tract rather than the kidneys: most of a dose and its metabolites are recovered in feces, with less than 1% recovered in urine.

Two practical takeaways follow from that:

• Because CYP3A4 does most of the metabolic work, other drugs or supplements that strongly affect CYP3A4 could, in principle, change how orforglipron is processed. Our orforglipron drug interactions guide covers what the label says about combining orforglipron with other medications.
• Because clearance is mainly hepatic/GI rather than renal, this half-life data is about liver-driven metabolism — it isn’t the same thing as kidney function, which is a separate consideration your prescriber would evaluate independently.

How long until orforglipron reaches steady state?

Going the other direction — building up rather than clearing out — the FDA label indicates orforglipron reaches steady-state concentrations after about one week of once-daily dosing at a given dose level.

That’s worth separating from the titration schedule, which paces dose increases much more slowly (each step at least 30 days) for tolerability reasons, not because the drug takes a month to build up in your blood. You reach a stable level on any given dose roughly a week after starting it; the label just doesn’t let you move to the next dose that fast. If you’ve missed doses and are wondering how that affects your levels or your restart plan, see Missed a Dose of Orforglipron?.

Clearance timeline at a glance

Question	What the FDA label indicates
Elimination half-life	Approximately 29–49 hours
Time to steady state	About 1 week of once-daily dosing
Primary metabolism pathway	Hepatic, mainly via CYP3A4
Primary elimination route	Feces (majority of dose); less than 1% in urine
Rough estimate to substantially clear (5 half-lives)	About 6–10 days after last dose (estimate, not a label-stated figure)

For contrast, once-weekly injectable GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are, by design, dosed on a weekly cycle — a different pharmacokinetic profile suited to their own dosing schedule. Neither MedlinePlus consumer drug page publishes a specific half-life figure the way the FOUNDAYO label does, so this article doesn’t attach a number to those comparisons; if you’re taking one of those drugs, ask your prescriber or check its own FDA labeling for specifics.

Why this timeline matters in practice

A half-life measured in days rather than hours means orforglipron doesn’t leave your system the moment you stop taking it. A few situations where that’s relevant:

• Before surgery or a procedure. GLP-1 receptor agonists as a class can slow gastric emptying, which surgical and anesthesia teams sometimes factor into pre-procedure planning. Whether and how long to pause orforglipron before a procedure is a decision for your surgical team and prescriber, not something to work out from a half-life number alone.
• Starting a new medication. Because orforglipron can still be present and affecting gastric emptying for days after your last dose, tell any new prescriber that you’re on orforglipron — and roughly when you last took it — so they can weigh possible interactions accurately.
• Stopping orforglipron altogether, or switching to another treatment. Appetite and GI effects may ease gradually over the clearance window described above rather than disappearing the day after your last dose — the same window that’s relevant if you’re switching to orforglipron from another treatment or timing a change the other direction. That’s a normal pharmacokinetic pattern, not a sign anything went wrong. Our orforglipron side effects guide covers what those lingering GI effects can look like day to day.

None of this is a substitute for guidance from your prescriber, who can apply this timeline to your specific health situation, other medications, and any upcoming procedures.

Bottom line

Orforglipron’s FDA-label elimination half-life of roughly 29 to 49 hours means the drug takes about a week to reach steady state after starting a dose, and roughly 6 to 10 days to substantially clear after the last dose, based on standard pharmacology estimates applied to that half-life. It’s metabolized in the liver via CYP3A4 and eliminated mainly through the digestive tract rather than the kidneys. If timing around surgery, a new medication, or stopping treatment matters for you, loop in your prescriber — they can apply this general timeline to your specific circumstances. For the full dosing picture, see the Foundayo (Orforglipron) guide.